Expertise in
16
conditions

Elisabetta Bugianesi

Turin, IT 
Expertise in
16
conditions
Turin, IT 

Overview

Elisabetta Bugianesi practices practicing medicine in Turin, Italy.

Ms. Bugianesi is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Cirrhosis, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Endoscopy.

She is actively involved in clinical research, co-authoring 315 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Turin, Italy
Other Locations
Forest And Food Sciences, Largo Paolo Braccini 2, Grugliasco, 10095, Italy
Trento, Italy
Bologna, Italy
Trani, 76125, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
View 1 Less Clinical Trial

315 Total Publications

Chicken bone-derived peptides: characterization and effects on human gut microbiota using the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®).
Chicken bone-derived peptides: characterization and effects on human gut microbiota using the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®).
Journal: Food & function
Published: August 10, 2026

Frequently Asked Questions about Elisabetta Bugianesi

Is Elisabetta Bugianesi a top-rated expert for Non-Alcoholic Fatty Liver Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Elisabetta Bugianesi is classified as an Elite expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Elisabetta Bugianesi participate in research or clinical trials?

Yes. Elisabetta Bugianesi has published 315 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Elisabetta Bugianesi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bugianesi's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile